Cleerly

Cleerly

Private
Denver, ColoradoHealthcare & Life Scienceshttps://www.cleerlyhealth.com

Last Round

Series C

Extension

12/4/2024

Total Funding Raised

$383M

Momentum Score

25 /100

Company Overview

Cleerly is a healthcare technology company that offers a non-invasive, AI-driven platform for quantifying and characterizing plaque buildup in coronary arteries, aiming to enhance the identification of at-risk patients for early treatment and prevention of heart attacks.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, Precision Medicine

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

CCTA analysisplaque analysisAI cardiac imagingcoronary artery diseasepreventive cardiologynoninvasive FFRFFRctFDA-cleared AIstenosis quantificationischemia detectionheart attack predictioncardiovascular imagingAI imaging platformvalue-based careCPT code reimbursement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cleerly Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cleerly Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series C Extension12/4/2024
Series C7/25/2022
Series B6/21/2021
Series A4/3/2020

Cleerly Investors

Notable investors and investment history

InvestorRounds
Breyer CapitalSeries C
DigiTx PartnersSeries B, Series C
New Leaf Venture PartnersSeries B, Series C
Heartland Healthcare CapitalSeries C
Cigna VenturesSeries B, Series C
Fidelity Management & Research CompanySeries C
Novartis Venture FundSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 14, 2026

    Accused of infringing on six patents related to AI diagnostic tools.

  • Mar 25, 2026

    Launched Cleerly PREVIEW for CAD imaging case prioritization.

Cleerly Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cleerly Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cleerly's valuation, stock price, and market status.

Firmographic Details

HeadquartersDenver, Colorado
Employee Range310
Year Founded2017
Last Funding12/4/2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.